440 related articles for article (PubMed ID: 35324674)
21. Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins.
Ciceri P; Cozzolino M
Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34073439
[TBL] [Abstract][Full Text] [Related]
22. Accumulation of protein-bound uremic toxins: the kidney remains the leading culprit in the gut-liver-kidney axis.
Jourde-Chiche N; Burtey S
Kidney Int; 2020 Jun; 97(6):1102-1104. PubMed ID: 32444090
[TBL] [Abstract][Full Text] [Related]
23. The Influence of OAT1 Density and Functionality on Indoxyl Sulfate Transport in the Human Proximal Tubule: An Integrated Computational and In Vitro Study.
King J; Mihaila SM; Ahmed S; Truckenmüller R; Giselbrecht S; Masereeuw R; Carlier A
Toxins (Basel); 2021 Sep; 13(10):. PubMed ID: 34678967
[TBL] [Abstract][Full Text] [Related]
24. Rationale for a New Classification of Solutes of Interest in Chronic Kidney Disease and Hemodialysis.
Reis T; Hutchison C; de Assis Rocha Neves F; Zawadzki B; Zanella M; Ronco C; Rosner MH
Blood Purif; 2023; 52(3):242-254. PubMed ID: 36657410
[TBL] [Abstract][Full Text] [Related]
25. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease.
Wu CL; Tarng DC
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419312
[TBL] [Abstract][Full Text] [Related]
26. Food-Derived Uremic Toxins in Chronic Kidney Disease.
Lauriola M; Farré R; Evenepoel P; Overbeek SA; Meijers B
Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828430
[TBL] [Abstract][Full Text] [Related]
27. Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver.
Sato T; Yamaguchi H; Kogawa T; Abe T; Mano N
J Pharm Pharm Sci; 2014; 17(4):475-84. PubMed ID: 25579430
[TBL] [Abstract][Full Text] [Related]
28. Challenges of reducing protein-bound uremic toxin levels in chronic kidney disease and end stage renal disease.
Faria M; de Pinho MN
Transl Res; 2021 Mar; 229():115-134. PubMed ID: 32891787
[TBL] [Abstract][Full Text] [Related]
29. Truncated domains of human serum albumin improves the binding efficiency of uremic toxins: A surface plasmon resonance and computational approach.
Nerusu A; Vaikuntapu PR; Chinthapalli DK; Podile AR; Subramanyam R
Int J Biol Macromol; 2020 Jul; 155():1216-1225. PubMed ID: 31734369
[TBL] [Abstract][Full Text] [Related]
30. Update on the pharmacokinetics and redox properties of protein-bound uremic toxins.
Watanabe H; Miyamoto Y; Otagiri M; Maruyama T
J Pharm Sci; 2011 Sep; 100(9):3682-95. PubMed ID: 21538353
[TBL] [Abstract][Full Text] [Related]
31. Bioengineered Kidney Tubules Efficiently Clear Uremic Toxins in Experimental Dialysis Conditions.
Faria J; Ahmed S; Stamatialis D; Verhaar MC; Masereeuw R; Gerritsen KGF; Mihăilă SM
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569805
[TBL] [Abstract][Full Text] [Related]
32. P
Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
[TBL] [Abstract][Full Text] [Related]
33. Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees.
Rapp N; Evenepoel P; Stenvinkel P; Schurgers L
Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 33003628
[TBL] [Abstract][Full Text] [Related]
34. Tryptophan-Derived Uremic Toxins and Thrombosis in Chronic Kidney Disease.
Addi T; Dou L; Burtey S
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30322010
[TBL] [Abstract][Full Text] [Related]
35. SLC22A11 Inserts the Uremic Toxins Indoxyl Sulfate and P-Cresol Sulfate into the Plasma Membrane.
Tust M; Müller JP; Fischer D; Gründemann D
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894870
[TBL] [Abstract][Full Text] [Related]
36. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.
Ito S; Yoshida M
Toxins (Basel); 2014 Feb; 6(2):665-78. PubMed ID: 24561478
[TBL] [Abstract][Full Text] [Related]
37. What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis.
Vanholder R; Nigam SK; Burtey S; Glorieux G
Toxins (Basel); 2022 Mar; 14(3):. PubMed ID: 35324718
[TBL] [Abstract][Full Text] [Related]
38. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.
Filipska I; Winiarska A; Knysak M; Stompór T
Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33920096
[TBL] [Abstract][Full Text] [Related]
39. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
[TBL] [Abstract][Full Text] [Related]
40. Mitochondria as a Source and a Target for Uremic Toxins.
Popkov VA; Silachev DN; Zalevsky AO; Zorov DB; Plotnikov EY
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
